See All Slides - tctmd.com

Slides

Presentation TCT 2018

Long-Term Outcomes of LM PCI vs CABG: New Insights From the MAIN-COMPARE and IRIS-MAIN Registries

Presenter: Raj Makkar, Patrick W. Serruys, Duk-Woo Park

September 23, 2018

Presentation TCT 2018

Experiences With Next Generation MitraClip: What Are the Meaningful Differences?

Presenter: Ted Feldman, Joachim Schofer, Saibal Kar

September 23, 2018

Presentation TCT 2018

Spain Discusses: How Would I Approach This Patient (and Cardiogenic Shock in General)?

Presenter: David W.M. Muller, Armando Perez de Prado, Niels van Royen, Raul Moreno

September 23, 2018

Presentation TCT 2018

Consensus: Considerations In The High Bleeding Risk Patient Requiring PCI And Oral Anticoagulant Therapy

Presenter: George D. Dangas, Giuseppe Tarantini, Roxana Mehran

September 23, 2018

Presentation TCT 2018

Clinical Impact of Valve Thrombosis After TAVR

Presenter: Martina Kelly Speight

September 23, 2018

Presentation TCT 2018

LEADERS FREE II: Summary and Clinical Implications

Presenter: Andreas Baumbach, Stephan Windecker, Mitchell W. Krucoff

September 23, 2018

Presentation TCT 2018

COMPASS Trial Revisited: Weighing Rivaroxaban Secondary Prevention vs DAPT After PCI

Presenter: Deepak L. Bhatt, Tullio Palmerini, Michael Maeng

September 23, 2018

Presentation TCT 2018

Endovascular Aortic Repairs: Historical Perspectives

Presenter: Robert A. Lookstein, Virendra I Patel, Darren B Schneider

September 23, 2018

Presentation TCT 2018

Case #2 Conclusion: How Did I Actually Treat This Patient?

Presenter: George D. Dangas, Giuseppe Tarantini, Steven R. Bailey, Giovanni Esposito, Juan F. Granada, Roxana Mehran, Francesco Saia

September 23, 2018

Presentation TCT 2018

MitraClip Patient Selection 2018: Can We Predict An Excellent Result (Sustained MR Less Than or Equal to 1+)?

Presenter: Ted Feldman, Joachim Schofer, Karl-Heinz Kuck

September 23, 2018

Advertisement

Slides

Long-Term Outcomes of LM PCI vs CABG: New Insights From the MAIN-COMPARE and IRIS-MAIN Registries

Experiences With Next Generation MitraClip: What Are the Meaningful Differences?

Spain Discusses: How Would I Approach This Patient (and Cardiogenic Shock in General)?

Consensus: Considerations In The High Bleeding Risk Patient Requiring PCI And Oral Anticoagulant Therapy

Clinical Impact of Valve Thrombosis After TAVR

LEADERS FREE II: Summary and Clinical Implications

COMPASS Trial Revisited: Weighing Rivaroxaban Secondary Prevention vs DAPT After PCI

Endovascular Aortic Repairs: Historical Perspectives

Case #2 Conclusion: How Did I Actually Treat This Patient?

MitraClip Patient Selection 2018: Can We Predict An Excellent Result (Sustained MR Less Than or Equal to 1+)?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content